After crackdown on spurious medicines, India’s drug regulator collating data of pharma plants
The companies have also been asked to share information on international approvals obtained from the European Union, US Food and Drug Administration, Japan's Pharmaceuticals and Medical Devices Agency, Brazilian Health Regulatory Agency (Anvisa), among other regulatory bodies abroad.
Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.
